Evaluation of the Feasibility of Screening for Paediatric Non-alcoholic Fatty Liver Disease

Overview

Journal Acta Paediatr

Specialty Pediatrics

Date 2022 Jul 28

PMID 35899429

Authors

Laura Draijer

Maaike Voorhoeve

Marc Benninga

Bart Koot

Affiliations

Soon will be listed here.

Abstract

Aim: To evaluate the feasibility of screening for non-alcoholic fatty liver disease (NAFLD) in clinical practice and the acceptance of a screening strategy, and to identify factors that determine compliance.

Methods: A screening protocol, based on alanine aminotransferase measurement and introduced to healthcare workers of Dutch outpatient obesity clinics in 2017, was evaluated. Medical files of children who visited the largest outpatient obesity clinic between 2017 and 2020 were evaluated. Focus group discussions (FGDs) were conducted with 14 healthcare workers who had been using the screening protocol.

Results: Screening for NAFLD was performed in 477/571 (84%) of the children. Loss of follow-up was the major reason for inadequate screening. Follow-up was performed in 81/134 children with an abnormal screening result (61%). The FGDs indicated 13 barriers for screening, regarding guideline- and knowledge-related issues.

Conclusion: Screening for NAFLD was performed in the vast majority of the children. However, adherence to the guideline after an abnormal initial screening result needs to be improved. This can be achieved by improving the loss of follow-up of patients' and physicians' awareness of the relevance of mildly elevated ALT levels.

Citing Articles

Evaluation of the feasibility of screening for paediatric non-alcoholic fatty liver disease.

Draijer L, Voorhoeve M, Benninga M, Koot B Acta Paediatr. 2022; 111(12):2408-2415.

PMID: 35899429 PMC: 9804620. DOI: 10.1111/apa.16502.

References

Ekstedt M, Hagstrom H, Nasr P, Fredrikson M, Stal P, Kechagias S . Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2014; 61(5):1547-54. DOI: 10.1002/hep.27368. View

Ferguson A, Xanthakos S, Siegel R . Challenges in Screening for Pediatric Nonalcoholic Fatty Liver Disease. Clin Pediatr (Phila). 2017; 57(5):558-562. DOI: 10.1177/0009922817733300. View

Dulai P, Singh S, Patel J, Soni M, Prokop L, Younossi Z . Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis. Hepatology. 2017; 65(5):1557-1565. PMC: 5397356. DOI: 10.1002/hep.29085. View

Molleston J, White F, Teckman J, Fitzgerald J . Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol. 2002; 97(9):2460-2. DOI: 10.1111/j.1572-0241.2002.06003.x. View

de Wilde J, van Dommelen P, Middelkoop B . Appropriate body mass index cut-offs to determine thinness, overweight and obesity in South Asian children in the Netherlands. PLoS One. 2013; 8(12):e82822. PMC: 3868582. DOI: 10.1371/journal.pone.0082822. View

de Onis M, Onyango A, Borghi E, Siyam A, Nishida C, Siekmann J . Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007; 85(9):660-7. PMC: 2636412. DOI: 10.2471/blt.07.043497. View

Koot B, van der Baan-Slootweg O, Tamminga-Smeulders C, Pels Rijcken T, Korevaar J, van Aalderen W . Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement. Arch Dis Child. 2011; 96(7):669-74. DOI: 10.1136/adc.2010.199760. View

Feldstein A, Charatcharoenwitthaya P, Treeprasertsuk S, Benson J, Enders F, Angulo P . The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut. 2009; 58(11):1538-44. PMC: 2792743. DOI: 10.1136/gut.2008.171280. View

Schwimmer J . Clinical advances in pediatric nonalcoholic fatty liver disease. Hepatology. 2016; 63(5):1718-25. PMC: 4843821. DOI: 10.1002/hep.28441. View

10.

Marengo A, Jouness R, Bugianesi E . Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults. Clin Liver Dis. 2016; 20(2):313-24. DOI: 10.1016/j.cld.2015.10.010. View

11.

Schwimmer J, Newton K, Awai H, Choi L, Garcia M, Ellis L . Paediatric gastroenterology evaluation of overweight and obese children referred from primary care for suspected non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013; 38(10):1267-77. PMC: 3984047. DOI: 10.1111/apt.12518. View

12.

Lazarus J, Ekstedt M, Marchesini G, Mullen J, Novak K, Pericas J . A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe. J Hepatol. 2019; 72(1):14-24. DOI: 10.1016/j.jhep.2019.08.027. View

13.

Cleveland E, Ning H, Vos M, Lewis C, Rinella M, Carr J . Low Awareness of Nonalcoholic Fatty Liver Disease in a Population-Based Cohort Sample: the CARDIA Study. J Gen Intern Med. 2019; 34(12):2772-2778. PMC: 6854130. DOI: 10.1007/s11606-019-05340-9. View

14.

Grattagliano I, DAmbrosio G, DAmbrozio G, Palmieri V, Moschetta A, Palasciano G . Improving nonalcoholic fatty liver disease management by general practitioners: a critical evaluation and impact of an educational training program. J Gastrointestin Liver Dis. 2008; 17(4):389-94. View

15.

Yu E, Golshan S, Harlow K, Angeles J, Durelle J, Goyal N . Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity. J Pediatr. 2018; 207:64-70. PMC: 6440815. DOI: 10.1016/j.jpeds.2018.11.021. View

16.

Chan D, Nelson E, Li A, Woo J, Sea M, Chan R . Lifestyle intervention in obese Chinese adolescents with non-alcoholic fatty liver disease: a randomised controlled study. Hong Kong Med J. 2018; 24 Suppl 4(4):12-15. View

17.

Armstrong M, Adams L, Canbay A, Syn W . Extrahepatic complications of nonalcoholic fatty liver disease. Hepatology. 2013; 59(3):1174-97. DOI: 10.1002/hep.26717. View

18.

Draijer L, Voorhoeve M, Benninga M, Koot B . Evaluation of the feasibility of screening for paediatric non-alcoholic fatty liver disease. Acta Paediatr. 2022; 111(12):2408-2415. PMC: 9804620. DOI: 10.1111/apa.16502. View

19.

Younossi Z, Koenig A, Abdelatif D, Fazel Y, Henry L, Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2015; 64(1):73-84. DOI: 10.1002/hep.28431. View

20.

Vos M, Abrams S, Barlow S, Caprio S, Daniels S, Kohli R . NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology.... J Pediatr Gastroenterol Nutr. 2017; 64(2):319-334. PMC: 5413933. DOI: 10.1097/MPG.0000000000001482. View